3rd Non-Viral RNA Delivery Systems Summit

Temas de la conferencia
There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.

Organizador profesional (PCO)
Hanson Wade

Observaciones
URL:
Brochure: https://go.evvnt.com/2422307-3?pid=4832

Speakers: Andrew Geall, Co-Founder and Chief Development Officer, Replicate Bioscience, Anna Perdrix, Founder and Co-Chief Executive Officer, Sixfold Bioscience, and more

https://go.evvnt.com/2422307-2?pid=4832

Ms. Lauren Thursby